Article
Cytologic atypia is predictive of increased risk of malignancy and BRAF mutations in thyroid follicular neoplasms (Bethesda category IV).
Journal of the American Society of Cytopathology - 1 Jan 2026
Dean Maureen A, Emiliani Francesco, Levy Joshua, Rodrigues Simoes Nathalie J, Coconubo Daniel Martinez, Gutmann Edward, Vaickus Louis, Marotti Jonathan, Kerr Darcy A, Liu Xiaoying
Abstract excerpt
INTRODUCTION: Molecular testing on thyroid fine needle aspirations with indeterminate cytology is integral to patient management. The aim of this study was to investigate the risk of malignancy in nodules diagnosed as Bethesda category IV, follicular neoplasm (FN), with and without cytologic atypia. MATERIALS AND METHODS: A total of 186 thyroid fine needle aspirations classified as Bethesda category IV (FN) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
